HIGHLIGHTS
- who: Jean-Baptiste Lascarrou et al. from the (UNIVERSITY) have published the research: RESEARCH Open Access, in the Journal: (JOURNAL) of 31/Dec/2021
- what: The aim of this study was to evaluate whether intermediate-dose prophylactic anticoagulation in patients with COVID-19 requiring ICU admission was associated with better outcomes compared to standard-dose prophylactic anticoagulation. Given the non-randomised design of the study , the authors adjusted the statistical analyses on the main known determinant of ICU mortality, namely, the SAPS II score , and on early corticosteroid therapy defined as started before or within . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.